the market?
CEL-SCI Corp
NYSEMKT: CVM
0.26
0.00
(-1.14%)
| Today's Open | $0.26 |
|---|---|
| Previous Close | $0.26 |
| Daily Range | $0.26 - $0.27 |
| 52-Week Range | $0.21 - $0.56 |
| Market Cap | $80.4M |
| P/E Ratio | -6.58 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 540,533 |
| Average Daily Volume | 1,163,402 |
| Current FY EPS | -$0.06 |
How do you think CVM
will perform against the market?
Top CVM Bull/Bear Pitches
zzlangerhans (< 20)
Submitted
June 13, 2011
I can already hear the gasps of horror. Yes, I meant to green thumb Cel-Sci. Even though the strategy has failed me horribly on stinkers like Hemispheryx, Rexahn, and Stemcells I still can't resist th … More
DarthMaul09 (< 20)
Submitted
October 16, 2009
Purely speculative bet that the 25% increase in stock price today was a bit excessive, although it was no were near the pop in had in August. I'm just a little pessimistic that the company can delive … More
News & Commentary
CEL-SCI Presents Data Showing LEAPS Vaccine is Successful in Reducing Rheumatoid Arthritis Index Sco
CEL-SCI To Present at the American Association of Immunologists 100th Annual Meeting on Saturday May
CEL-SCI Corporation Announces That NIAID Collaborators Have Submitted Bird Flu Study for Publication
Sector
Healthcare
Industry
Drugs
CEL-SCI Corp (CVM) Description
The Company engages in the research and development of drugs and vaccines. Its most advanced product, Multikine, manufactured using the Company's proprietary cell culture technologies, is being developed for the treatment of cancer. Website: http://www.cel-sci.com/
